BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1527507)

  • 1. Demonstration of the intracellular production of tissue-destructive protease by Legionella pneumophila multiplying within guinea-pig and human alveolar macrophages.
    Rechnitzer C; Williams A; Wright JB; Dowsett AB; Milman N; Fitzgeorge RB
    J Gen Microbiol; 1992 Aug; 138 Pt 8():1671-7. PubMed ID: 1527507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between the legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages. Influence of antibody, lymphokines, and hydrocortisone.
    Nash TW; Libby DM; Horwitz MA
    J Clin Invest; 1984 Sep; 74(3):771-82. PubMed ID: 6470140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differing macrophage and lymphocyte roles in resistance to Legionella pneumophila infection.
    Yamamoto Y; Klein TW; Newton C; Friedman H
    J Immunol; 1992 Jan; 148(2):584-9. PubMed ID: 1729375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Legionella pneumophila cytotoxic protease on human neutrophil and monocyte function.
    Rechnitzer C; Kharazmi A
    Microb Pathog; 1992 Feb; 12(2):115-25. PubMed ID: 1584005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of an isogenic Zn-metalloprotease-deficient mutant of Legionella pneumophila in a guinea-pig pneumonia model.
    Moffat JF; Edelstein PH; Regula DP; Cirillo JD; Tompkins LS
    Mol Microbiol; 1994 Jun; 12(5):693-705. PubMed ID: 8052122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-10 enhances the growth of Legionella pneumophila in human mononuclear phagocytes and reverses the protective effect of IFN-gamma: differential responses of blood monocytes and alveolar macrophages.
    Park DR; Skerrett SJ
    J Immunol; 1996 Sep; 157(6):2528-38. PubMed ID: 8805654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia.
    Edelstein PH; Shinzato T; Doyle E; Edelstein MA
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2204-9. PubMed ID: 11451675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of ABT-773 against Legionella pneumophila, its pharmacokinetics in guinea pigs, and its use to treat guinea pigs with L. pneumophila pneumonia.
    Edelstein PH; Higa F; Edelstein MA
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2685-90. PubMed ID: 11557455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo production of a tissue-destructive protease by Legionella pneumophila in the lungs of experimentally infected guinea-pigs.
    Conlan JW; Williams A; Ashworth LA
    J Gen Microbiol; 1988 Jan; 134(1):143-9. PubMed ID: 3053969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical demonstration of the association between Legionella pneumophila, its tissue-destructive protease, and pulmonary lesions in experimental legionnaires' disease.
    Williams A; Baskerville A; Dowsett AB; Conlan JW
    J Pathol; 1987 Nov; 153(3):257-64. PubMed ID: 3323432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Legionella pneumophila replicates within rat alveolar epithelial cells.
    Mody CH; Paine R; Shahrabadi MS; Simon RH; Pearlman E; Eisenstein BI; Toews GB
    J Infect Dis; 1993 May; 167(5):1138-45. PubMed ID: 8486946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temperature effects on Legionella pneumophila killing by and multiplication in phagocytes of guinea pigs.
    Miyamoto H; Ogawa M; Maruta K; Nikaido Y; Yamamoto C; Taniguchi H; Yoshida S
    Microbiol Immunol; 1995; 39(9):647-54. PubMed ID: 8577277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunopathogenesis of Legionnaires' disease].
    Alim A
    Mikrobiyol Bul; 2004 Jul; 38(3):295-303. PubMed ID: 15490851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of caspase 3 during Legionella pneumophila-induced apoptosis.
    Gao LY; Abu Kwaik Y
    Infect Immun; 1999 Sep; 67(9):4886-94. PubMed ID: 10456945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential virulence role of the Legionella pneumophila ptsP ortholog.
    Higa F; Edelstein PH
    Infect Immun; 2001 Aug; 69(8):4782-9. PubMed ID: 11447151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence of Legionella pneumophila to guinea pig peritoneal macrophages, J774 mouse macrophages, and undifferentiated U937 human monocytes: role of Fc and complement receptors.
    Husmann LK; Johnson W
    Infect Immun; 1992 Dec; 60(12):5212-8. PubMed ID: 1452353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity in intracellular replication and cytopathogenicity of Legionella pneumophila and Legionella micdadei in mammalian and protozoan cells.
    Gao LY; Susa M; Ticac B; Abu Kwaik Y
    Microb Pathog; 1999 Nov; 27(5):273-87. PubMed ID: 10545255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of oxidative burst and chemotaxis in human phagocytes by Legionella pneumophila zinc metalloprotease.
    Sahney NN; Summersgill JT; Ramirez JA; Miller RD
    J Med Microbiol; 2001 Jun; 50(6):517-525. PubMed ID: 11393289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Icm/Dot-dependent inhibition of phagocyte migration by Legionella is antagonized by a translocated Ran GTPase activator.
    Simon S; Wagner MA; Rothmeier E; Müller-Taubenberger A; Hilbi H
    Cell Microbiol; 2014 Jul; 16(7):977-92. PubMed ID: 24397557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and intracellular activities of LBM415 (NVP PDF-713) against Legionella pneumophila.
    Edelstein PH; Hu B; Edelstein MA
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2533-5. PubMed ID: 15917565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.